SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®,induces robust humoral and cellular immunity in mice andnon-human primates

| Published Research Articles

SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®,induces robust humoral and cellular immunity in mice andnon-human primates 🔬 Introduction In the race to develop effective vaccines against COVID-19, Iranian researchers have designed an innovative mRNA-based vaccine candidate known as COReNAPCIN®. Using a lipid nanoparticle (LNP) delivery system, this vaccine aims to safely express the full-length SARS-CoV-2 spike (S) protein […]

SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®,induces robust humoral and cellular immunity in mice andnon-human primates Read Post »